SCP
ACHV icon

Sender Company & Partners’s Achieve Life Sciences ACHV Stock Holding History

Sender Company & Partners’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-25,000
Closed -$78.8K – 108
2025
Q3 		$78.8K Hold
25,000
– – 0.01% 448
2025
Q2 		$56.5K Buy
+25,000
New +$71.2K 0.02% 271

Other funds holding ACHV

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sender Company & Partners's ACHV Position: Q4 2025 in Review

Sender Company & Partners sold out of Achieve Life Sciences (ACHV) in Q4 2025, closing a stake of 25,000 shares — an estimated $78.8K sold.

Sender Company & Partners first reported a position in ACHV in Q2 2025 and held it in 2 quarters. The position peaked at $78.8K in Q3 2025. 77 funds tracked by Wall St. Rank hold ACHV as of Q4 2025.

  • Sender Company & Partners reported no remaining Achieve Life Sciences position as of Q4 2025 after selling out during the quarter.
  • Sender Company & Partners sold 25,000 Achieve Life Sciences shares in Q4 2025, an estimated $78.8K.
  • Sender Company & Partners first reported a position in Achieve Life Sciences in Q2 2025 and held it in 2 quarters.
  • Sender Company & Partners's Achieve Life Sciences position peaked at $78.8K in Q3 2025.
  • 77 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q4 2025.

Based on Sender Company & Partners's 13F filing for Q4 2025, filed 17 Feb 2026.